Oncology (all articles)
Randomized Trial: Treatment vs. Observation in Smoldering Multiple Myeloma
30 Oct, 2019 | 08:15h | UTCCommentary: Lenalidomide may delay onset of myeloma-related bone, organ damage – Mayo Clinic (free)
The Global Burden of Pancreatic Cancer
30 Oct, 2019 | 07:59h | UTCInvited Commentary: Pancreatic cancer: a growing burden (free)
Related Commentary on Twitter
New research: Globally, the number of deaths, incident cases, and DALYs caused by #pancreaticcancer has more than doubled from 1990 to 2017 – https://t.co/ErtopvrIP5 #UEGWeek #GBDStudy @IHME_UW #pancsm pic.twitter.com/8L7sdjAGtm
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) October 22, 2019
The Global Burden of Colorectal Cancer
30 Oct, 2019 | 07:55h | UTCInvited Commentary: The global challenge of colorectal cancer (free)
Related Commentary on Twitter
New research: In 2017, there were 1·8 million incident cases of #colorectalcancer worldwide; the age-standardised incidence rate showed an increase of 9·5% from 1990 to 2017 – https://t.co/lqAbA8nKJL #UEGWeek #GBDStudy @IHME_UW #crcsm pic.twitter.com/juXBZ6Xcgo
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) October 22, 2019
The Global Burden of Gastric Cancer
30 Oct, 2019 | 07:57h | UTCInvited Commentary: 27 years of stomach cancer: painting a global picture (free)
Related Commentary on Twitter
New research: Global estimates of the burden of #stomachcancer suggest there were more than 1·22 million incident cases worldwide in 2017; more than half these occurred in #China – https://t.co/NrC1nNaNPX #GBDStudy #UEGweek @IHME_UW #stcsm pic.twitter.com/mPRb9YmDsp
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) October 22, 2019
Machine Learning Approaches to Predict 6-Month Mortality Among Patients with Cancer
27 Oct, 2019 | 23:34h | UTCCommentary: Algorithm Identifies Cancer Patients in Need of Advance Care Planning Conversations – Penn Medicine (free)
Perspective: Older Patients (Still) Left Out of Cancer Clinical Trials
27 Oct, 2019 | 23:36h | UTCOlder Patients (Still) Left Out of Cancer Clinical Trials – JAMA (free for a limited period)
Related: Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details – BMJ Open (free) AND Do cancer clinical trials exaggerate the real-world benefits of drugs? – STAT News (free)
Related Commentary on Twitter
Medication without representation: People 65 years or older are strikingly underrepresented in cancer clinical trials, even though most cancers occur in that age group. Via @JAMA_current https://t.co/IxWBqHAZIB pic.twitter.com/67YxklJIs1
— Muin J. Khoury (@MuinJKhoury) October 26, 2019
Interest in Cannabidiol Products Keeps Soaring Despite Limited Evidence in Humans
27 Oct, 2019 | 19:29h | UTCTrends in Internet Searches for Cannabidiol (CBD) in the United States – JAMA Network Open (free)
Commentaries: Interest in CBD products keeps soaring, but health experts wary – HealthDay (free) AND Online Searches For CBD Skyrocket – MedicalResearch.com (free)
Related Commentary on Twitter
"Interest in CBD products keeps soaring, but health experts wary" https://t.co/TP50a31bbP via @medical_xpress
"At this time there are no known benefits for taking CBD over-the-counter. #CBD is this generation's snake oil…"
Studies "in humans are still limited…"#CBDHype.
— Timothy Caulfield (@CaulfieldTim) October 25, 2019
Cohort Study: Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality
27 Oct, 2019 | 19:27h | UTCCommentary: Association between 5α-reductase inhibitors, prostate cancer mortality replicated – Medicine Matters (free)
Related Study: Use of 5α-reductase Inhibitors is Associated with Delayed Prostate Cancer Diagnosis and Increased Mortality in Men Undergoing PSA Screening (link to abstract and commentary)
Study: Pan-cancer Whole-genome Analyses of Metastatic Solid Tumors
25 Oct, 2019 | 08:41h | UTCPan-cancer whole-genome analyses of metastatic solid tumours – Nature (free)
Commentaries: Huge whole-genome study of human metastatic cancers – Nature (free) AND Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer – MedicalXpress (free)
Study: Cigarette Type May Influence Lung Cancer Incidence and Mortality
24 Oct, 2019 | 08:21h | UTCAssociation of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial – JAMA Internal Medicine (free for a limited period)
Commentaries: Lung cancer incidence and mortality varies by cigarette type – OnMedica (free) AND Lung cancer risk 40% greater in unfiltered cigarette smokers – Healio (free registration required)
Opinion: “Progression-Free Survival” – How One Bit of Medical Jargon Fuels Public Confusion About Cancer Treatments
24 Oct, 2019 | 07:55h | UTCHow one bit of medical jargon fuels public confusion about cancer treatments – Health News Review (free)
Related: Study: Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology (link to abstract and commentaries)
Review: Pulmonary Complications of Immune Checkpoint Inhibitors in Patients with Nonsmall Cell Lung Cancer
23 Oct, 2019 | 07:18h | UTCRelated: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
The Cancer Atlas
20 Oct, 2019 | 23:09h | UTCThe Cancer Atlas, 3rd Edition – American Cancer Society (free PDF)
News Release: Progress in global cancer fight is not only possible, but achievable – American Cancer Society (free)
NICE Guideline: End of Life Care for Adults
17 Oct, 2019 | 08:35h | UTCEnd of life care for adults: service delivery – National Institute for Health and Care Excellence (free)
Related: Clinical Practice Guidelines for Quality Palliative Care, 4th Edition – National Consensus Project’s (free)
Exercise is Medicine in Oncology: Engaging Clinicians to Help Patients Move Through Cancer
17 Oct, 2019 | 08:37h | UTCSee also: Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable – Medicine & Science in Sports & Exercise (free) AND American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control – Medicine & Science in Sports & Exercise (free)
Commentaries: Exercise can now be prescribed like medicine for people with and beyond cancer – Penn State College of Medicine (free) AND Expert Panel: Cancer Treatment Plans Should Include Tailored Exercise Prescriptions – American College of Sports Medicine (ACSM) (free) AND Panel Finds Exercise May Lower Cancer Risk, Improve Outcomes – NIH Director’s Blog (free) AND Exercise Advice for Surviving Cancer, and Maybe Avoiding It – The New York Times (10 articles per month are free)
Case Report: Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
16 Oct, 2019 | 08:38h | UTCRelated Reviews: Cardiotoxicity of immune checkpoint inhibitors – ESMO Open (free) AND Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature (free) AND Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology – Journal of the Formosan Medical Association (free)
See also: Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
Guideline: Endoscopic Management of Lynch Syndrome and Familial Risk of Colorectal Cancer
16 Oct, 2019 | 08:35h | UTC
Meta-Analysis: Comparison of Treatments for Advanced EGFR Mutated Non-small Cell Lung Cancer
14 Oct, 2019 | 08:03h | UTC
Perspective: Alternative Payment for Radiation Oncology
10 Oct, 2019 | 09:15h | UTCAlternative Payment for Radiation Oncology – JAMA (free for a limited period)
Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms
10 Oct, 2019 | 09:08h | UTC
NCCN Guidelines Insights: Multiple Myeloma
10 Oct, 2019 | 09:05h | UTCNCCN Guidelines Insights: Multiple Myeloma, Version 1.2020 – National Comprehensive Cancer Network (free)
NCCN Guideline: Distress Management
10 Oct, 2019 | 09:06h | UTC
Imaging of Precision Therapy for Lung Cancer: Current State of the Art
8 Oct, 2019 | 09:37h | UTCImaging of Precision Therapy for Lung Cancer: Current State of the Art – Radiology (free)
Consensus Statement: Liquid Biopsy in Oncology
8 Oct, 2019 | 09:17h | UTC
ESMO Guideline: Thyroid Cancer
7 Oct, 2019 | 00:52h | UTC